FEBS LETTERS
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
FEBS LETTERS
FEBS LETT
ISSN / eISSN
0014-5793 / 1873-3468
Aims and Scope
FEBS Letters is one of the world's leading journals in molecular biology and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, Research Letters and Hypotheses that merit urgent publication.
Subject Area
BIOCHEMISTRY & MOLECULAR BIOLOGY
BIOPHYSICS
CELL BIOLOGY
CiteScore
7.00
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Biochemistry, Genetics and Molecular Biology - Biophysics | Q1 | #29/143 |
Biochemistry, Genetics and Molecular Biology - Genetics | Q2 | #95/328 |
Biochemistry, Genetics and Molecular Biology - Biochemistry | Q2 | #141/428 |
Biochemistry, Genetics and Molecular Biology - Structural Biology | Q2 | #16/45 |
Biochemistry, Genetics and Molecular Biology - Molecular Biology | Q2 | #158/380 |
Biochemistry, Genetics and Molecular Biology - Cell Biology | Q2 | #116/274 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE | Q3 |
BIOPHYSICS - SCIE | Q2 |
CELL BIOLOGY - SCIE | Q3 |
H-index
238
Country/Area of Publication
NETHERLANDS
Publisher
Wiley-Blackwell
Publication Frequency
Biweekly
Year Publication Started
1968
Annual Article Volume
258
Open Access
NO
Contact
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started